Form: EFFECT

Notice of Effectiveness

August 5, 2024

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: August 5, 2024 4:00 P.M.
Form: S-3
CIK: 0001534120
Company Name: Avalo Therapeutics, Inc.
File Number: 333-279992